Intravitreal injections are used to treat multiple age-related and vascular diseases of the fundus. These include wet age-related macular degeneration, macular edema due to complications of diabetes mellitus or retinal vein thrombosis, uveitis, etc.
In S. Fyodorov Eye Microsurgery Federal State Institution we use anti-VEGF agents Eylea (Bayer, Germany) and Lucentis (Novartis Pharma, Switzerland) and also intravitreal dexamethasone implant Ozurdex (Allergan, Ireland).
To determine the treatment strategy, all patients undergo retinal examination using the most modern equipment. Intravital injections are given in a sterile operating room, which is crucial for ensuring the safety of treatment.